Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUDG.L Regulatory News (UDG)

  • There is currently no data for UDG

Form 8.3 - UDG LN

28 Jul 2021 15:30

RNS Number : 7950G
Syquant Capital
28 July 2021
Β 

Ap19

Β 

Β 

FORMΒ 8.3

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANEL ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ PERSONSΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β ORΒ MORE

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

Syquant Capital

Company dealt in

UDG Healthcare plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

EUR 0.05 ordinary shares

Date of dealing

July 27th, 2021

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Β 

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

Β 

Β 

(2) Derivatives (other than options)

6,536,997 (2.59%)

Β 

(3) Options and agreements to purchase/sell

Β 

Β 

Total

6,536,997 (2.59%)

Β 

Β Β Β Β Β Β Β 

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Class of relevant security:

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

Β 

Β 

Β 

(2) Derivatives (other than options)

Β 

Β 

Β 

(3) Options and agreements to purchase/sell

Β 

Β 

Total

Β 

Β 

Β Β Β Β Β Β Β 

Β 

Ap20

Β 

Β 

1. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Β 

Purchase/sale

Β 

Number of relevant securities

Β 

Price per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Β 

Β 

Β 

Increasing a long position

Β 

51,236

1077.00 GBp

Β 

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Β 

Β 

Β 

Β 

Ap21

Β 

2. OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

Β 

Β 

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ 

anyΒ otherΒ personΒ relatingΒ toΒ theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ 

onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ 

whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.Β IfΒ none,Β this shouldΒ beΒ stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) Β YES/NO

Β 

Date of disclosure

July 28th, 2021

Contact name

Alexandre Chevtchenko

Telephone number

+33 1 42 56 92 93

If a connected EFM, name of offeree/offeror with which connected

Β 

If a connected EFM, state nature of connection (Note 10)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ISEDKFBPBBKDQOB
Date   Source Headline
30th Jul 202111:30 amRNSForm 38.5(b) - UDG Healthcare plc
30th Jul 202111:28 amRNSForm 38.5(a) - UDG Healthcare plc
30th Jul 202111:22 amRNSForm 8.5 (EPT/RI) - UDG Healthcare Plc
30th Jul 20219:57 amRNSForm 8.3 - UDG Healthcare plc
30th Jul 20219:23 amRNSForm 38.5(a) (EPT/RI)
29th Jul 20214:31 pmRNSUDG Healthcare Plc 38.5a
29th Jul 20214:30 pmRNSUDG Healthcare Plc 38.5a
29th Jul 20214:30 pmRNSHolding(s) in Company
29th Jul 20214:29 pmRNSUDG Healthcare Plc 38.5a
29th Jul 20214:29 pmRNSUDG Healthcare Plc 38.5a
29th Jul 20214:28 pmRNSUDG Healthcare Plc 38.5a
29th Jul 20214:28 pmRNSUDG Healthcare Plc 38.5a
29th Jul 20214:26 pmRNSUDG Healthcare Plc 38.5a
29th Jul 20214:25 pmRNSUDG Healthcare Plc 38.5a
29th Jul 20213:30 pmRNSForm 8.3 - UDG LN
29th Jul 20213:30 pmGNWForm 8.3 - UDG Healthcare plc
29th Jul 20213:20 pmRNSForm 8.3 - UDG Healthcare Plc
29th Jul 20213:15 pmBUSForm 8.3 - UDG Healthcare plc
29th Jul 20213:01 pmEQSForm 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc
29th Jul 20212:42 pmRNSForm 8.3 - UDG Healthcare plc
29th Jul 202112:02 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - UDG Healthcare plc - Ordinary shares
29th Jul 202111:44 amRNSUDG Healthcare Plc 38.5b
29th Jul 202111:41 amRNSUDG Healthcare Plc 38.5a
29th Jul 202111:12 amBUSForm 8.3 - UDG HEALTHCARE PLC
29th Jul 202110:58 amRNSForm 38.5(a) - UDG Healthcare plc
29th Jul 202110:33 amRNSForm 8.5 (EPT/RI) - UDG Healthcare Plc
29th Jul 20219:59 amRNSForm 38.5a UDG Healthcare plc
29th Jul 20219:12 amRNSForm 38.5(a) (EPT/RI)
29th Jul 20218:48 amRNSForm 8.3 - UDG Healthcare plc
28th Jul 20216:15 pmRNSUDG Healthcare Plc 38.5a amend
28th Jul 20216:15 pmRNSUDG Healthcare Plc 38.5a amend
28th Jul 20216:13 pmRNSUDG Healthcare Plc 38.5a amend
28th Jul 20216:12 pmRNSUDG Healthcare Plc 38.5a amend
28th Jul 20216:10 pmRNSUDG Healthcare Plc 38.5a amend
28th Jul 20216:10 pmRNSUDG Healthcare Plc 38.5a amend
28th Jul 20216:07 pmRNSUDG Healthcare Plc 38.5a amend
28th Jul 20214:30 pmRNSHolding(s) in Company
28th Jul 20213:30 pmRNSForm 8.3 - UDG LN
28th Jul 20213:20 pmRNSForm 8.3 - UDG Healthcare Plc
28th Jul 20213:15 pmBUSForm 8.3 - UDG Healthcare plc
28th Jul 20212:35 pmGNWForm 8.3 - UDG Healthcare plc
28th Jul 20212:18 pmBUSForm 8.3 - UDG HEALTHCARE PLC
28th Jul 20212:02 pmEQSForm 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc
28th Jul 202112:03 pmRNSForm 8.3 - UDG Healthcare PLC
28th Jul 202111:49 amRNSUDG Healthcare Plc 38.5b
28th Jul 202111:47 amRNSUDG Healthcare Plc 38.5a
28th Jul 202110:45 amRNSForm 38.5(a) - UDG Healthcare plc
28th Jul 202110:22 amRNSForm 8.5 (EPT/RI) - UDG Healthcare Plc
28th Jul 20219:17 amRNSForm 38.5(a) (EPT/RI)
28th Jul 20217:00 amRNSForm 8.3 - UDG Healthcare plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.